Standardized cranberry capsules for radiation cystitis in prostate cancer patients in New Zealand: a randomized double blinded, placebo controlled pilot study

Supportive Care in Cancer

Volumn 23, Issue 1, 2015, Pages 95-102

  Hamilton, Katelin ^a   Bennett, Noelle C ^a   Purdie, Gordon ^b   Herst, Patries M ^c  

^a DUNEDIN HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cranberry capsules; Double blinded; Placebo capsules; Radiation cystitis; Randomized

Indexed keywords

CRANBERRY CAPSULE; PLACEBO; PROANTHOCYANIDIN DERIVATIVE; RADIOPROTECTIVE AGENT; UNCLASSIFIED DRUG; PLANT MEDICINAL PRODUCT;

ADULT; AGED; ARTICLE; BLADDER EMPTYING; BURNING SENSATION; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRANBERRY; CYSTITIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFECT; HUMAN; HYDRATION; INTENSITY MODULATED RADIATION THERAPY; MALE; MEAL; MODIFIED EXPANDED PROSTATE INDEX COMPOSITE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEW ZEALAND; OUTCOME ASSESSMENT; PILOT STUDY; PROSTATE CANCER; RADIATION CYSTITIS; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; UROGENITAL TRACT DISEASE; ADVERSE EFFECTS; BLADDER; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; PATHOLOGY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIATION RESPONSE; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CYSTITIS; DOUBLE-BLIND METHOD; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW ZEALAND; PILOT PROJECTS; PLACEBOS; PLANT PREPARATIONS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME; URINARY BLADDER; URINARY TRACT INFECTIONS; VACCINIUM MACROCARPON;

EID: 84919952716     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2335-8     Document Type: Article

References (27)

1. New Zealand Cancer Registry (NZCR), Ministry of Health – Manatū Hauora, 2013. http://www.health.govt.nz/publication/cancer-selected-sites-2010-2011-2012
2. McCammon R, Rusthoven KE, Kavanagh B, Newell S, Newman F, Raben D (2009) Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer. Int J Radiat Oncol Biol Phys 75:413–420
3. Pervez N, Small C, MacKenzie M, Yee D, Parliament M, Ghosh S, Mihai A, Amanie J, Murtha A, Field C, Murray D, Fallone G, Pearcey R (2010) Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 76:57–64
4. Cowan CC, Hutchison C, Cole T, Barry SJE, Paul J, Reed NS, Russell JM (2012) A randomised double-blind placebo-controlled trial to determine the effect of cranberry juice on decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing radiotherapy for cancer of the bladder or cervix. Clin Oncol 24:e31–e38
5. Antonakopoulos GN, Hicks RM, Berry RJ (1984) The subcellular basis of damage to the human urinary bladder induced by irradiation. J Pathol 143:103–116
6. Engles CD, Hauser PJ, Abdullah SN, Culkin DJ, Hurst RE (2012) Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage “leaky bladder” model of cystitis. Urology 79(2):483.e13-7
7. Giberti C, Gallo F, Cortese PS, Shenone M (2013) Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study. Ther Adv Urol 5:175–179
8. Porru D, Leva F, Parmigiani A, Barletta D, Choussos D, Gardella B, Daccò MD, Nappi RE, Allegri M, Tinelli C, Bianchi CM, Spinillo A, Rovereto B (2012) Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int Urogynecol J 23:1193–1199
9. Hisano M, Bruschini H, Nicodemo A, Srougi M (2012) Cranberries and lower urinary tract infection prevention. Clinics 67:661–667
10. Jepson RG, Williams G, Craig JC (2012) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. doi:10.1002/14651858.CD001321.pub5
11. Brown PN, Turi CE, Shipley PR, Murch SJ (2012) Comparisons of large (Vaccinium macrocarpon Ait.) and small (Vaccinium oxycoccos L., Vaccinium vitis-idaea L.) cranberry in British Columbia by phytochemical determination, antioxidant potential, and metabolomic profiling with chemometric analysis. Planta Med 78:630–640
12. Cesonienė L, Daubaras R, Jasutienė I, Venclovienė J, Miliauskiene I (2011) Evaluation of the biochemical components and chromatic properties of the juice of Vaccinium macrocarpon Aiton and Vaccinium oxycoccos L. Plant Foods Hum Nutr 66:238–244
13. Côté J, Caillet S, Doyon G, Sylvain JF, Lacroix M (2010) Bioactive compounds in cranberries and their biological properties. Crit Rev Food Sci Nutr 50:666–679
14. Kylli P, Nohynek L, Puupponen-Pimiä R, Westerlund-Wikström B, Leppänen T, Welling J, Moilanen E, Heinonen M (2011) Lingonberry (Vaccinium vitis-idaea) and European cranberry (Vaccinium microcarpon) proanthocyanidins: isolation, identification, and bioactivities. J Agric Food Chem 59:373–3384
15. Caillet S (2012) Free Radical-scavenging properties and antioxidant activity of fractions from cranberry products. Food Nutr Sci 03:337–347
16. Rajbhandari R, Peng N, Moore R, Arabshahi A, Wyss JM, Barnes SP, Prasain JK (2011) Determination of cranberry phenolic metabolites in rats by liquid chromatography-tandem mass spectrometry. J Agric Food Chem 59:6682–6688
17. Milbury PE, Cao G, Prior RL, Blumberg J (2002) Bioavailablility of elderberry anthocyanins. Mech Ageing Dev 123:997–1006
18. Milbury PE, Vita JA, Blumberg JB (2010) Anthocyanins are bioavailable in humans following an acute dose of cranberry juice. J Nutr 140:1099–10104
19. Ohnishi R, Ito H, Kasajima N, Kaneda R, Karyama R, Kumon H, Hatano T, Yoshida T (2006) Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem 70:1681–1687
20. Karlsen A, Retterstøl L, Laake P, Paur I, Bøhn SK, Sandvik L, Blomhoff R (2007) Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 137:1951–1954
21. Campbell G, Pickles T, D’yachkova Y (2003) A randomised trial of cranberry versus apple juice in the management of urinary symptoms during external beam radiation therapy for prostate cancer. Clin Oncol 15:322–328
22. Bonetta A, Di Pierro F (2012) Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma. Cancer Manag Res 4:281–286
23. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG (2000) Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899–905
24. Hedgepeth RC, Labo J, Zhang L, Wood DP (2009) Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy. J Urol 182:221–227, discussion 227–8
25. Conover WJ, Iman RL (1981) IRL. Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 35:124–129
26. Erickson DR, Herb N, Ordille S, Harmon N, Bhavanandan VP (2000) A new direct test of bladder permeability. J Urol 164:419–422
27. Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP (2010) Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis 10:94. doi:10.1186/1471-2334-10-94, 2010;10:1–11